Metabolism of doxorubicin in long-term bone marrow cultures and SR-4987 stromal established cell line

Drug Metabolism and Drug Interactions

Volumn 15, Issue 4, 1999, Pages 279-291

  Gribaldo, Laura ^a   Catalani, Paolo ^a   Erminio, Marafante ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

Bone marrow; Cell culture; Doxorubicin; Metabolism; SR 4987 cell line

Indexed keywords

DOXORUBICIN;

ANIMAL CELL; BONE MARROW CULTURE; CELL FRACTIONATION; CLONOGENESIS; COLONY FORMING UNIT GM; CONTROLLED STUDY; DETOXIFICATION; DRUG METABOLISM; DRUG TRANSFORMATION; LIVER CELL CULTURE; MOUSE; NONHUMAN; RAT; REVIEW; STROMA CELL;

EID: 0032752379     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.1999.15.4.279     Document Type: Review

References (30)

1. Wierda D, Updyke LW, Gaido K. Bone marrow stromal cell cultures. In: Tyson CA, Frazier JM, eds. Methods in Toxicology, Vol. 1A, In Vitro Biological Systems. London: Academic Press, 1993; 492-503.
2. Hays EF, Hale L, Villareal B, Fitchen JH. Stromal and hemopoietic stem cell abnormalities in long-term cultures of marrow from busulfan-treated mice. Exp Hematol 1982; 10: 383-388.
3. Harigaya K, Miller ME, Cronkite EP, Drew RT. The detection of in vivo hematotoxicity of benzene by in vitro liquid bone marrow cultures Toxicol Appl Pharmacol 1981; 60: 346-353.
4. Wierda D, Greenle WF. Integrating in vitro systems with animal models in mechanistic studies of immunotoxic agents. In: Miller K, Turk J, Nicklin S, eds. Principles and Practice of Immunotoxicology. Oxford: Blackwell Scientific Publications, 1992; 324-343.
5. Naughton BA, Sibanda D, Azar L, San Roman J. Differential effects of drugs upon hematopoiesis can be assessed in long-term bone marrow cultures established on nylon screens. Proc Soc Exp Biol Med 1992; 199: 481-490.
6. Myers SR, Flesher JW. Metabolism of the carcinogen 3-methylcholantrene in human bone marrow preparations. Drug Metab Disposition 1990; 18: 664-669.
7. Ganousis LG, Goon D, Zyglewska T, Wu KK, Ross D. Cell-specific metabolism in mouse bone marrow stroma: studies of activation and detoxification of benzene metabolism. Mol Pharmacol 1992; 42: 1118-1125.
8. Dexter TM, Spooncer E, Simmons P, Allen TD. Long-term marrow culture: An overview of techniques and experience. In: Wright DG, Greenberger JS, eds. Long-term Bone Marrow Culture. New York: Alan R. Liss, 1984; 57-96.
9. Thomas DJ, Sadlere A, Subrahmanyam VV, Siegel D, Reasor MJ, Wierda D, Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophage and fibroblastoid cells. Mol Pharmacol 1990; 37: 255-262.
10. Pessina A, Mineo E, Neri MG, Gribaldo L, Colombi R, Brambilla P, Zaleskis G. Establishment and characterization of a new murine cell line (SR-4987) derived from marrow stromal cells. Cytotechnology 1992; 8: 93-102.
11. Gribaldo L, Bueren J, Deldar A, Hokland P, Meredith C, Moneta D, Mosesso P, Parchment R, et al. The use of in vitro systems for evaluating haematotoxicity. ATLA 1996; 24: 211-231.
12. Davis HL, Davis TE. Daunorubicin and adriamycin in cancer treatment: An analysis of the roles and limitations. Cancer Treatment Rev 1979; 63: 809-812.
13. Benjamin RS, Riggs CE Jr, Bachur NR. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res 1977; 37: 1416-1420.
14. Gewirtz DA, Yanovich S. Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit. Biochem Pharmacol 1987; 36: 1793-1798.
15. Dexter TM, Allen TD, Lajtha LJ. Conditions controlling the proliferation of haematopoietic stem cells in vitro. J Cell Physiol 1977; 91: 335-344.
16. Seglen PO. Preparation of isolated rat liver cells. Meth Cell Biol 1976; 13: 29-83.
17. Bradley TR, Metcalf D. The growth of murine bone marrow cells in vitro. Aust J Exp Biol Med Sci 1966; 44: 287-300.
18. Griffiths A. Centrifugal techniques. In: Wilson K, Walker J, eds. Principles and Techniques of Practical Biochemistry Cambridge: Cambridge University Press, 1994; 283-330.
19. Doroshow JH. Anthracyclines and anthracenediones. In: Chabner BA, Longo DL, eds. Cancer Chemotherapy and Biotherapy. Philadelphia, PA: Lippincott-Raven, 1996; 409-434.
20. Bronchud MH, Margison JM, Howell A. Comparative pharmakokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer. Cancer Chemother Pharmacol 1990; 25: 435-442.
21. Pratt WB, Ruddon RW. The antibiotics. In: Pratt WB, Ruddon RW, eds. The Anticancer Drugs. New York: Oxford University Press, 1979; 148-194.
22. Twerdock LE, Rembish SJ, Trush MA. Induction of quinone reductase and glutathione in bone marrow cells by l,2-dithiole-3-thione: Effect on hydroquinone-induced cytotoxicity. Toxicol Appl Pharmacol 1992; 112: 272-277.
23. Thomas DJ, Reasor MJ, Wierda D. Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol Appl Pharmacol 1989; 97: 440-453.
24. Moore MAS, Sheridan P, Allen TD, Dexter TD. Prolonged hematopoiesis in a primate bone marrow culture system: Characteristics of stem cell production and the hematopoietic microenvironment. Blood 1979; 54: 775-793.
25. Lerat H, Lissitzky JC, Singer JW, Keating A, Herve P, Charbord P. Role of stromal cells and macrophages in fibronectin biosynthesis and matrix assembly in human long-term marrow cultures. Blood 1993; 82: 1480-1492.
26. Takahashi M, Keating A, Singer JW. A functional defect in irradiated adherent layers from chronic myelogenous leukemia long-term marrow cultures. Exp Hematol 1985; 13: 926-935.
27. Pessina A, Neri MG, Mineo E, Piccirillo M, Gribaldo L, Brambilla P, et al. Expression of B cell markers on SR-4987 cells derived from murine bone marrow stroma. Exp Hematol 1997; 25: 536-541.
28. Cocke KS, Updyke LW, Wierda D. Mouse bone marrow stromal cells can accumulate and release cytotoxic concentrations of doxorubicin into the hematopoietic microenvironment. In vitro Toxicol 1993; 6: 243-256.
29. Tidefelt U, Sundman-Engberg B, Paul C. Intracellular uptake and cytotoxic effect in vitro of doxorubicin and epirubicin in human leukemic and normal hematopoietic cells. Cancer Chemother Pharmacol 1991; 29: 7-12.
30. Testa NG. Long-term bone marrow damage after cytotoxic treatment. In: Testa NG, ed. Hematopoiesis, Long Term Effects of Chemotherapy and Radiation. New York: Marcel Dekker, 1988; 63-73.